Use of -Blockers and the Risk of Hip/Femur Fracture in the United Kingdom and The Netherlands

Author： Vries F. Souverein P. Cooper C. Leufkens H. Staa T.

ISSN： 0171-967X

Source： Calcified Tissue International, Vol.80, Iss.2, 2007-02, pp. : 69-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fracture Risk in Perimenopausal Women Treated with Beta-Blockers

By Rejnmark Lars Vestergaard Peter Kassem Moustapha Christoffersen Bo Kolthoff Niels Brixen Kim Mosekilde Leif

Calcified Tissue International, Vol. 75, Iss. 5, 2004-11 ,pp. : 365-372

Springer Publishing Company

Access to resources Recommend Favorite

Beta-Blockers: Effects on Bone Mineral Density and Fracture Risk

Current Rheumatology Reviews, Vol. 2, Iss. 4, 2006-11 ,pp. : 353-357

Bentham Science Publishers

Access to resources Recommend Favorite

β-Blockers and Diuretics in the Treatment of Hypertension: `A Friendly Fire?'

By Volpe Massimo

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 3, 2008-01 ,pp. : 109-111

Adis International

Access to resources Recommend Favorite

Knee Arthroplasty and Risk of Hip Fracture: A Population-Based, Case-Control Study

By Lalmohamed Arief

Calcified Tissue International, Vol. 90, Iss. 2, 2012-02 ,pp. : 144-150

Springer Publishing Company

Access to resources Recommend Favorite

Bone density and geometry in assessing hip fracture risk in post-menopausal women

By Gnudi S Sitta E Fiumi N

British Journal of Radiology, Vol. 80, Iss. 959, 2007-11 ,pp. : 893-897

British Institute of Radiology

Access to resources Recommend Favorite